Tuesday, September 11, 2012

Why don't you reduce cancer drug price, SC asks Novartis | ummid.com

Why don't you reduce cancer drug price, SC asks Novartis | ummid.com
Pharma major Novartis AG Tuesday said it was the author of beta crystalline, a form of a compound used in an anti-cancer drug, while the Supreme Court asked the company why it could not reduce its medicine's price.